A study comparing the effectiveness of two pharmacologically distinct medications used to treat opioid use disorder – a buprenorphine/naloxone combination and an extended release naltrexone [...]
What: The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, will [...]
Contact:NIDA Press Office301-443-6245media@nida.nih.gov About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of [...]
SAMHSA’s recently released annual National Survey on Drug Use and Health (NSDUH) provides insights into substance use and mental health in the United States. Updated [...]
Every September, as a part of National Recovery Month, SAMHSA celebrates people who have achieved long-term recovery from mental and substance use disorders and those who provide [...]
Courtesy of Marco Venniro A team of researchers at the National Institute on Drug Abuse (NIDA) has identified what may be the crucial brain circuit [...]
Despite current treatment guidelines, fewer than 10 percent of adults with co-occurring mental health and substance use disorders receive treatment for both disorders, and more [...]
Photo by NIDA New research suggests that marijuana users may be more likely than nonusers to misuse prescription opioids and develop prescription opioid use disorder. [...]
The National Institute on Drug Abuse (NIDA) announced that the latest Monitoring the Future (MTF) national survey results of drug use among full-time college students [...]
Elinore F. McCance-Katz, M.D., Ph.D., has been appointed Assistant Secretary for Mental Health and Substance Use. Dr. McCance-Katz works across federal agencies to address the [...]